Inhibition of the Tissue Factor-Thrombin Pathway Limits Infarct Size after Myocardial Ischemia-Reperfusion Injury by Reducing Inflammation

This publication has 61 references indexed in Scilit:

• Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial
  The Lancet, 1999
• Comparison of the Effects of the Thrombin Inhibitor r-Hirudin in Four Animal Models of Neointima Formation After Arterial Injury
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina
  Journal of the American College of Cardiology, 1995
• Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
  Genes & Development, 1995
• Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion.
  Journal of Clinical Investigation, 1991
• Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
  Cell, 1991
• Conservation of tissue factor primary sequence among three mammalian species
  Gene, 1991
• Reocclusion after thrombolysis
  Blood Coagulation & Fibrinolysis, 1991
• Monoclonal Antibodies to a Synthetic Fibrin-Like Peptide Bind to Human Fibrin But Not Fibrinogen
  Science, 1983